Learn more about supplements for lung health, including vitamins, minerals, and herbs that support breathing, reduce ...
Most cases of nocardiosis start out as lung infections, in which pus-filled cavities, or abscesses containing the bacteria, ...
The death of actor and leading man Val Kilmer is a stark reminder of how one of the most common lung infections in the ...
From a thorough history going back decades to a mass meeting of experts, identifying occupational lung diseases can be ...
In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension ...
A new diagnostic tool developed by physicians and scientists from UNSW Sydney that analyses a person’s breath for signs of silicosis has the potential to catch the disease earlier rather than wait for ...
The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...
A larger diameter of the main pulmonary artery predicts poorer outcomes in pulmonary arterial hypertension (PAH) patients, a study found.
The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results